S. Colman

Publications by Year

Research Areas

Blood Pressure and Hypertension Studies, Heart Failure Treatment and Management, Antiplatelet Therapy and Cardiovascular Diseases, Acute Ischemic Stroke Management, Hormonal Regulation and Hypertension

Most-Cited Works

• → The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition(2003)139 cited
• → Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease(2005)79 cited
• → Once‐daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double‐blind, randomized, paroxetine‐controlled, non‐inferiority trial in China, Korea, Taiwan and Brazil(2007)51 cited
• → Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease(2005)46 cited
• → Soluble Vascular Cell Adhesion Molecule 1 and N-terminal Pro–B-Type Natriuretic Peptide in Predicting Ischemic Stroke in Patients With Cerebrovascular Disease(2005)45 cited
• → Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease(2004)40 cited
• → Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease(2007)9 cited
• → Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease(2007)8 cited
• Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.(2007)
• Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA(2005)